None
Quote | electroCore Inc. (NASDAQ:ECOR)
Last: | $6.2394 |
---|---|
Change Percent: | -3.51% |
Open: | $5.9 |
Close: | $6.2394 |
High: | $6.35 |
Low: | $5.8 |
Volume: | 5,649 |
Last Trade Date Time: | 04/30/2024 03:00:00 am |
News | electroCore Inc. (NASDAQ:ECOR)
Enact Holdings Inc. (ACT) is expected to report $0.99 for Q1 2024 FormFactor Inc. (FORM) is expected to report $0.09 for Q1 2024 SAAB AB - Class B (SAABF) is expected to report for quarter end 2024-03-31 Lumos Pharma Inc. (LUMO) is expected to report $-1.21 for Q1 2024 Axis Capita...
ROCKAWAY, N.J., April 30, 2024 (GLOBE NEWSWIRE) -- electroCore, Inc. (the “Company”), (NASDAQ: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced the results of its most recent Truvaga Plus consumer study conducted earlier this year. Based on a 30...
Message Board Posts | electroCore Inc. (NASDAQ:ECOR)
Subject | By | Source | When |
---|---|---|---|
$ECOR electroCore Inc | mick | investorshub | 04/30/2023 10:19:22 PM |
$ECOR electroCore Inc | mick | investorshub | 04/15/2023 6:28:10 PM |
$ECOR $7 on the deck | $Pistol Pete$ | investorshub | 04/11/2023 2:43:52 AM |
Let me know the company name and I | $Pistol Pete$ | investorshub | 03/27/2023 5:21:07 PM |
Thank you Peter. I hope all is going | longboarder7892 | investorshub | 03/27/2023 4:40:42 PM |
News, Short Squeeze, Breakout and More Instantly...
Enact Holdings Inc. (ACT) is expected to report $0.99 for Q1 2024 FormFactor Inc. (FORM) is expected to report $0.09 for Q1 2024 SAAB AB - Class B (SAABF) is expected to report for quarter end 2024-03-31 Lumos Pharma Inc. (LUMO) is expected to report $-1.21 for Q1 2024 Axis Capita...
ROCKAWAY, N.J., April 30, 2024 (GLOBE NEWSWIRE) -- electroCore, Inc. (the “Company”), (NASDAQ: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced the results of its most recent Truvaga Plus consumer study conducted earlier this year. Based on a 30...
2024-04-21 00:34:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...